Physiological variables and molecular study of KLK2 and KLK3 among patient with benign prostatic hyperplasia

Prostatic hyperplasia is benign tumor occur in prostate. Benign prostatic hyperplasia is common disease in old men. The incidence of disease arises with increase in age. The patient with benign prostatic hyperplasia are estimated 20% of men in 40s old, and 90% in of men in 80s old, and main causes o...

Full description

Bibliographic Details
Main Authors: Mustafa F. Dawood, Sameer M. Khalaf, Ahmed A. Suleiman
Format: Article
Language:English
Published: Taylor & Francis Group 2018-09-01
Series:Alexandria Journal of Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2090506817300076
_version_ 1818461640384839680
author Mustafa F. Dawood
Sameer M. Khalaf
Ahmed A. Suleiman
author_facet Mustafa F. Dawood
Sameer M. Khalaf
Ahmed A. Suleiman
author_sort Mustafa F. Dawood
collection DOAJ
description Prostatic hyperplasia is benign tumor occur in prostate. Benign prostatic hyperplasia is common disease in old men. The incidence of disease arises with increase in age. The patient with benign prostatic hyperplasia are estimated 20% of men in 40s old, and 90% in of men in 80s old, and main causes of prostatic hyperplasia are unknown but there is evidence referring to genetic and hormonal disorders that may cause the disease. This study includes 60 patients with prostatic hyperplasia with an average age of 64 years old and 30 samples as a control with same age group. The study obtained that there was significant association (P ≤ 0.05) between PSA (KLK3) and prostatic hyperplasia. Result also mentions that there was significant decrease in testosterone level and significant increase in dihydrotestosterone level. The present study for KLK2 and KLK3 genes showed molecular variation in both genes, varied between polymorphism and allele polymorphism. PCR amplification of specific primers of KLK2 gene showed polymorphisms ranged between 14%, 8%, 10%, and 6% in each KLK2a, KLK2b, KLK2c, and KLK2d primers respectively, while the allele polymorphism in KLK2c amplification with primer reaches 18% of patient. PCR amplification of specific primers of KLK3 gene showed polymorphisms ranged between 10%, 6%, 2%, and 4% in each KLK3a, KLK3b, KLK3c, and KLK3d primer respectively, and allele variation was not detected in amplification product of KLK3. Keywords: Hyperplasia, Prostatic specific antigen, KLK2, KLK3
first_indexed 2024-12-14T23:49:21Z
format Article
id doaj.art-7cf78ad8b10c4c028413990fa8e1a4c6
institution Directory Open Access Journal
issn 2090-5068
language English
last_indexed 2024-12-14T23:49:21Z
publishDate 2018-09-01
publisher Taylor & Francis Group
record_format Article
series Alexandria Journal of Medicine
spelling doaj.art-7cf78ad8b10c4c028413990fa8e1a4c62022-12-21T22:43:17ZengTaylor & Francis GroupAlexandria Journal of Medicine2090-50682018-09-01543203206Physiological variables and molecular study of KLK2 and KLK3 among patient with benign prostatic hyperplasiaMustafa F. Dawood0Sameer M. Khalaf1Ahmed A. Suleiman2Anbar University, College of Education for Pure Science, IraqAnbar University, College of Education for Pure Science, IraqAnbar University, College of Science, Iraq; Corresponding author.Prostatic hyperplasia is benign tumor occur in prostate. Benign prostatic hyperplasia is common disease in old men. The incidence of disease arises with increase in age. The patient with benign prostatic hyperplasia are estimated 20% of men in 40s old, and 90% in of men in 80s old, and main causes of prostatic hyperplasia are unknown but there is evidence referring to genetic and hormonal disorders that may cause the disease. This study includes 60 patients with prostatic hyperplasia with an average age of 64 years old and 30 samples as a control with same age group. The study obtained that there was significant association (P ≤ 0.05) between PSA (KLK3) and prostatic hyperplasia. Result also mentions that there was significant decrease in testosterone level and significant increase in dihydrotestosterone level. The present study for KLK2 and KLK3 genes showed molecular variation in both genes, varied between polymorphism and allele polymorphism. PCR amplification of specific primers of KLK2 gene showed polymorphisms ranged between 14%, 8%, 10%, and 6% in each KLK2a, KLK2b, KLK2c, and KLK2d primers respectively, while the allele polymorphism in KLK2c amplification with primer reaches 18% of patient. PCR amplification of specific primers of KLK3 gene showed polymorphisms ranged between 10%, 6%, 2%, and 4% in each KLK3a, KLK3b, KLK3c, and KLK3d primer respectively, and allele variation was not detected in amplification product of KLK3. Keywords: Hyperplasia, Prostatic specific antigen, KLK2, KLK3http://www.sciencedirect.com/science/article/pii/S2090506817300076
spellingShingle Mustafa F. Dawood
Sameer M. Khalaf
Ahmed A. Suleiman
Physiological variables and molecular study of KLK2 and KLK3 among patient with benign prostatic hyperplasia
Alexandria Journal of Medicine
title Physiological variables and molecular study of KLK2 and KLK3 among patient with benign prostatic hyperplasia
title_full Physiological variables and molecular study of KLK2 and KLK3 among patient with benign prostatic hyperplasia
title_fullStr Physiological variables and molecular study of KLK2 and KLK3 among patient with benign prostatic hyperplasia
title_full_unstemmed Physiological variables and molecular study of KLK2 and KLK3 among patient with benign prostatic hyperplasia
title_short Physiological variables and molecular study of KLK2 and KLK3 among patient with benign prostatic hyperplasia
title_sort physiological variables and molecular study of klk2 and klk3 among patient with benign prostatic hyperplasia
url http://www.sciencedirect.com/science/article/pii/S2090506817300076
work_keys_str_mv AT mustafafdawood physiologicalvariablesandmolecularstudyofklk2andklk3amongpatientwithbenignprostatichyperplasia
AT sameermkhalaf physiologicalvariablesandmolecularstudyofklk2andklk3amongpatientwithbenignprostatichyperplasia
AT ahmedasuleiman physiologicalvariablesandmolecularstudyofklk2andklk3amongpatientwithbenignprostatichyperplasia